期刊文献+

中西医药物联合方法治疗子宫肌瘤临床疗效评价 被引量:3

Evaluation of the Combined Method of Traditional Chinese Medicine and Western Medicine Clinical Curative Effect in the Treatment of Uterine Fibroids
下载PDF
导出
摘要 目的:分析子宫肌瘤采取中西医联合治疗的效果。方法:选择2012年3月—2014年9月我院治疗的子宫肌瘤患者68例,随机分为两组,观察组34例,给予中西医联合治疗,对照组34例,给予西医治疗。观察2组临床效果。结果:观察组痊愈、显效、有效33例,总有效率97.06%,对照组痊愈、显效、有效22例,总有效率为64.71%,有效率比较差异有统计学意义(P<0.05);观察组和对照组比较子宫肌瘤的体积缩小明显,差异有统计学意义(P<0.05)。结论:子宫肌瘤采用中西医联合治疗效果明显,子宫肌瘤的体积明显缩小,临床推广价值较高。 Objective : To analysis take the combiiled Chinese and western medicine treatment of uterine fibroids effect. Methods : 68 patients with uterine leiomyoma from 2012 March to 2014 September in our hospital treated patients, were randomly divided into 2 groups, the observation group 34 cases, given by combined Chinese and western medicine treatment, the control group of 34 cases, treated with western medicine therapy. Observe 2 groups of clinical efficacy. Results : In the observation group, 33 cases cured, markedly effective, the total efficiency of 97.06%, the control group cured, markedly effective, effective in 22 cases, the total effective rate was 64.71%, there was statistical significance difference with efficiency (P〈0.05) ; observation group and the control group of uterine myoma volume reduced obviously, the difference was statistically significant (P〈0.05). Conclusion: Uterine fibroids with combined therapy of Chinese traditional and Western medicine effect is obvious, the size of uterine fibroids significantly reduced,higher clinical value.
作者 杨丽媛 张琳
出处 《辽宁中医药大学学报》 CAS 2015年第8期183-184,共2页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 中西医药物 子宫肌瘤 临床疗效 traditional Chinese and western medicine myoma of uterus clinical effect
  • 相关文献

参考文献6

二级参考文献26

  • 1陈贵安 张丽珠.子宫肌瘤与组织胞浆内雌、孕激素受体含量及血内雌二醇、孕酮水平关系的探讨[J].中华妇产科杂志,1984,19(2):88-88.
  • 2Sato F,Miyake H,Nishi M,et al.Early normal menstrual cycle pattern and the development of uterineleiomyomas[J].J Women Heath Gend Based Med,2000,9(3):299-302.
  • 3arshall LM,Spiegelman,Barbieri RL,et al.Variation in the incidence of uterine leiomyoma among prenenopansal women by age andrace.Oblistet Gynecol,1990,90(6):967.
  • 4Blake RE,leiomyomata uteri:hormonal and molecular deteminants of growth[J].Natl Asssoc 2007,99,1170-1184.
  • 5Bulum S E,etal Clin Endocrionl Metalb,1994,78:736.
  • 6Lee BS,Nowak RA.Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 and altered responses to the antiproliferatlve effects of TGF beta[J].J Clin Endocrinol Metab,2001,86(2):913-920.
  • 7Gao ZJ,Matsuo H,Wang Y,et al.Upregulation by IGF-I of proliferating cell nuclear antigen and bel-2protein expression in human uterine leiomyoma cells[J].Clin Endocrinol Metab,2001,86(11):5593-5599.
  • 8Kovacs KA,Lengye IF,Komye i JL,et al.Differential expression of Akt/protein kinase B,bel-2 and bax proteins in human leiomyoma and myometrium[J].J Steroid Biochem Mol Biol,2003,87(425):233-240.
  • 9Wu X,Blanck A,Olovsson M,et al.Expression of bcl-2,bel-x,mcll,bax and bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause[J].J Steroid Biochem Mol Biol,2002,80(1):77-83.
  • 10Buttram VC Jr,Reiter RC.Uterine leiomyomata:etiology,symptomatology,and management[J].Fertil Steril,1981,36 (4):433 -445.

共引文献45

同被引文献16

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部